New partnership aims to close the gender health research gap through innovative AI-powered platform Copenhagen, September 11, 2024 – Femtech Insider, the globally leading platform for women’s health innovation, and Proem, a collaborative AI-powered research dissemination platform, today announced a groundbreaking partnership to make the latest women’s health research accessible to a wider and more diverse audience. This partnership, unveiled at TechBBQ…
The Rare Disease Diversity Coalition (RDDC) and the National Organization for Rare Disorders (NORD) have released findings from a comprehensive national survey that sheds light on the barriers faced by underrepresented patients with rare diseases. The survey, which included over 2,800 participants, offers crucial insights into the challenges of accessing healthcare and the disproportionate impact on communities of color. One of the…
A detailed map of the human endometrium, the inner lining of the uterus, has recently been released, offering new insights into the cellular processes that occur throughout the menstrual cycle. This research, which covers multiple phases of the cycle, has potential implications for understanding and treating conditions like endometriosis. The study, published in Nature Genetics, is part of the Human Cell Atlas…
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on novel treatments for severe ischemic diseases, has announced the initiation of a Phase 2 trial for their preeclampsia treatment, DM199. This announcement came alongside their second quarter 2024 financial results and business update. Preeclampsia (PE) is a serious pregnancy complication characterized by high blood pressure and damage to organ systems, often affecting the kidneys…
Johnson & Johnson has announced significant findings from their Phase 2 UNITY study of nipocalimab for the treatment of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN). The results, published in The New England Journal of Medicine, indicate that nipocalimab can delay or prevent severe fetal anemia and improve birth outcomes. HDFN occurs…
Materna Medical has announced the publication of clinical results in the International Urogynecology Journal. The study, titled “Effect of an intrapartum pelvic dilator device on levator ani muscle avulsion during primiparous vaginal delivery: A pilot randomized controlled trial,” highlights the safety and effectiveness of Materna’s Prep Device in reducing childbirth-related pelvic floor injuries in first-time mothers. The study reports that the use…
Washington Spirit, Olympique Lyonnais Féminin, and London City Lionesses owner Michele Kang has launched the Kynisca Innovation Hub (KIH), a non-profit initiative under Kynisca Sports International, that aims to transform training methods through science and data, unlocking the full athletic potential of female athletes. Despite growing investment in women’s sports, only 6% of sports science data is dedicated to female athletes. KIH…
In recent years, we have seen an increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies and their contributions to understanding and advancing women’s health. This round-up was created with help from our very own Femtech Bot. We welcome your feedback on content…
